1. Hepatocellular carcinoma: signaling pathways, targeted therapy, and immunotherapy
   Xiaoting Luo et al, 2024, MedComm CrossRef
2. The Protective Role of 4-Acetylarylquinolinol B in Different Pathological Processes
   Huijie Zhao et al, 2022, Current Issues in Molecular Biology CrossRef
3. Biological impact and therapeutic perspective of targeting PI3K/Akt signaling in hepatocellular carcinoma: Promises and Challenges
   Mahshid Deldar Abad Paskeh et al, 2023, Pharmacological Research CrossRef
4. Aerobic exercise suppresses hepatocellular carcinoma by downregulating dynamin-related protein 1 through PI3K/AKT pathway
   Tong Zhao et al, 2021, Journal of Integrative Medicine CrossRef
5. Apatinib plus drug-eluting bead transarterial chemoembolization as bridging therapy to surgical resection displays an acceptable efficacy and safety profile in hepatocellular carcinoma patients
   Jingwei Yan et al, 2023, Indian Journal of Cancer CrossRef
6. Low‐ dose Apatinib promotes vascular normalization and hypoxia reduction and sensitizes radiotherapy in lung cancer
   Shanshan Jiang et al, 2023, Cancer Medicine CrossRef
7. New advances in the research of clinical treatment and novel anticancer agents in tumor angiogenesis
   Xin Li et al, 2023, Biomedicine & Pharmacotherapy CrossRef
8. Apatinib plus chemotherapy is associated with an improved tumor response, survival and tolerance compared with chemotherapy alone for advanced lung adenocarcinoma treatment
   Hua Ye et al, 2024, Oncology Letters CrossRef
9. Mechanisms and Clinical Trials of Hepatocellular Carcinoma Immunotherapy
   Shao-Li Huang et al, 2021, Frontiers in Genetics CrossRef
10. The long-term efficacy and safety of apatinib are inferior to sorafenib in the first-line treatment of advanced hepatocellular carcinoma: A systematic review and meta-analysis
    Dailong Li et al, 2024, Medicine CrossRef
11. SPOCD1 regulated by miR-133a-3p promotes hepatocellular carcinoma invasion and metastasis
    Tianying Zheng et al, 2022, Journal of International Medical Research CrossRef
12. Echinacea purpurea suppresses the cell survival and metastasis of hepatocellular carcinoma through regulating the PI3K/Akt pathway
    Wenqian Xu et al, 2022, The International Journal of Biochemistry & Cell Biology CrossRef
13. Network analysis and the impact of Aflibercept on specific mediators of angiogenesis in HUVEC cells
    Hamid Latifi‐Navid et al, 2021, Journal of Cellular and Molecular Medicine CrossRef
14. Use of Apatinib as a Bait to Fish its Unexpected Kinase Targets from the Hepatocellular Carcinoma Druggable Kinome
    Rui Liu et al, 2023, Journal of Computational Biophysics and Chemistry CrossRef
15. Efficacy and safety of apatinib combined with liposomal doxorubicin or paclitaxel versus liposomal doxorubicin or paclitaxel monotherapy in patients with recurrent platinum‐resistant ovarian cancer
    Hailei Yang et al, 2023, Journal of Obstetrics and Gynaecology Research CrossRef
16. Bisphenol A Promotes the Progression of Colon Cancer Through Dual-Targeting of NADPH Oxidase and Mitochondrial Electron-Transport Chain to Produce ROS and Activating HIF-1α/VEGF/PI3K/AKT Axis
    Tianyi Xia et al, 2022, Frontiers in Endocrinology CrossRef
17. Physical activity and exercise in liver cancer
    Haiyan Chen et al, 2024, Liver Research CrossRef